{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:27:41Z","timestamp":1788546461358,"version":"build-2803163510"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T00:00:00Z","timestamp":1577318400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Calcium"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ceca.2019.102156","type":"journal-article","created":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T11:12:17Z","timestamp":1577445137000},"page":"102156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Endogenous cardiotonic steroids and cardiovascular disease, where to next?"],"prefix":"10.1016","volume":"86","author":[{"given":"Davor","family":"Pavlovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ceca.2019.102156_bib0005","series-title":"An Account of the Foxglove, and Some of Its Medical Uses: With Practical Remarks on Dropsy and Other Diseases","author":"Withering","year":"1785"},{"key":"10.1016\/j.ceca.2019.102156_bib0010","series-title":"Traite Clinique Des Maladies Du Cour","author":"B.J","year":"1835"},{"key":"10.1016\/j.ceca.2019.102156_bib0015","series-title":"Digitalis: Its Mode of Action","author":"F.J.M","year":"1871"},{"key":"10.1016\/j.ceca.2019.102156_bib0020","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/300650a0","article-title":"A circulating inhibitor of (Na+ + K+)ATPase associated with essential hypertension","volume":"300","author":"Hamlyn","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.ceca.2019.102156_bib0025","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1073\/pnas.88.14.6259","article-title":"Identification and characterization of a ouabain-like compound from human plasma","volume":"88","author":"Hamlyn","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ceca.2019.102156_bib0030","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1161\/01.HYP.13.6.681","article-title":"Isolation and characterization of a sodium pump inhibitor from human plasma","volume":"13","author":"Hamlyn","year":"1989","journal-title":"Hypertension"},{"key":"10.1016\/j.ceca.2019.102156_bib0035","doi-asserted-by":"crossref","first-page":"7395","DOI":"10.1016\/S0021-9258(18)83247-1","article-title":"Digitalis-like activity in human plasma. Purification, affinity, and mechanism","volume":"264","author":"Hamlyn","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ceca.2019.102156_bib0040","doi-asserted-by":"crossref","first-page":"14085","DOI":"10.1073\/pnas.0904817106","article-title":"Mutation I810N in the alpha3 isoform of Na+,K+-ATPase causes impairments in the sodium pump and hyperexcitability in the CNS","volume":"106","author":"Clapcote","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ceca.2019.102156_bib0045","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ajhg.2018.10.004","article-title":"Germline De Novo Mutations in ATP1A1 Cause Renal Hypomagnesemia, Refractory Seizures, and Intellectual Disability","volume":"103","author":"Schlingmann","year":"2018","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ceca.2019.102156_bib0050","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0006-3002(57)90343-8","article-title":"The influence of some cations on an adenosine triphosphatase from peripheral nerves","volume":"23","author":"Skou","year":"1957","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ceca.2019.102156_bib0055","doi-asserted-by":"crossref","first-page":"13742","DOI":"10.1073\/pnas.0907054106","article-title":"Crystal structure of the sodium-potassium pump (Na+,K+-ATPase) with bound potassium and ouabain","volume":"106","author":"Ogawa","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ceca.2019.102156_bib0060","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0014-5793(92)81530-Y","article-title":"Molecular basis for the insensitivity of the Monarch (Danaus plexippus) to cardiac glycosides","volume":"314","author":"Holzinger","year":"1992","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ceca.2019.102156_bib0065","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/molbev\/msg240","article-title":"Molecular adaptation of Chrysochus leaf beetles to toxic compounds in their food plants","volume":"21","author":"Labeyrie","year":"2004","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.ceca.2019.102156_bib0070","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0300-9629(96)00465-3","article-title":"Ouabain-sensitive Na+,K(+)-ATPase activity in toad brain","volume":"118","author":"Morris","year":"1997","journal-title":"Comp. Biochem. Physiol. A Physiol."},{"key":"10.1016\/j.ceca.2019.102156_bib0075","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0022-3565(25)28389-6","article-title":"The effect of ouabain on sodium- and potassium-activated adenosine triphosphatase from the hearts of several mammalian species","volume":"170","author":"Akera","year":"1969","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ceca.2019.102156_bib0080","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cardiores.2006.11.006","article-title":"Differential distribution and regulation of mouse cardiac Na+\/K+-ATPase alpha1 and alpha2 subunits in T-tubule and surface sarcolemmal membranes","volume":"73","author":"Berry","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ceca.2019.102156_bib0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/geno.2000.6274","article-title":"The FXYD gene family of small ion transport regulators or channels: cDNA sequence, protein signature sequence, and expression","volume":"68","author":"Sweadner","year":"2000","journal-title":"Genomics"},{"key":"10.1016\/j.ceca.2019.102156_bib0090","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yjmcc.2013.05.002","article-title":"Novel regulation of cardiac Na pump via phospholemman","volume":"61","author":"Pavlovic","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ceca.2019.102156_bib0095","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0014-5793(91)80801-9","article-title":"The functional role of the beta-subunit in the maturation and intracellular transport of Na,K-ATPase","volume":"285","author":"Geering","year":"1991","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ceca.2019.102156_bib0100","doi-asserted-by":"crossref","first-page":"8397","DOI":"10.1073\/pnas.88.19.8397","article-title":"Coexpression of alpha 1 with putative beta 3 subunits results in functional Na+\/K+ pumps in Xenopus oocytes","volume":"88","author":"Horisberger","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ceca.2019.102156_bib0105","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/cvr\/cvy221","article-title":"Heart failure leads to altered beta2-adrenoceptor\/cyclic adenosine monophosphate dynamics in the sarcolemmal phospholemman\/Na,K ATPase microdomain","volume":"115","author":"Bastug-Ozel","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ceca.2019.102156_bib0110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/cvr\/cvu182","article-title":"Cardiac hypertrophy in mice expressing unphosphorylatable phospholemman","volume":"104","author":"Boguslavskyi","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ceca.2019.102156_bib0115","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.yjmcc.2013.04.013","article-title":"Nitric oxide regulates cardiac intracellular Na(+) and Ca(2)(+) by modulating Na\/K ATPase via PKCepsilon and phospholemman-dependent mechanism","volume":"61","author":"Pavlovic","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ceca.2019.102156_bib0120","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1096\/fj.11-184903","article-title":"Phospholemman-dependent regulation of the cardiac Na\/K-ATPase activity is modulated by inhibitor-1 sensitive type-1 phosphatase","volume":"25","author":"El-Armouche","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.ceca.2019.102156_bib0125","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1146\/annurev.biochem.71.102201.141218","article-title":"Biochemistry of Na,K-ATPase","volume":"71","author":"Kaplan","year":"2002","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ceca.2019.102156_bib0130","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0304-4157(89)90019-1","article-title":"Isozymes of the Na+\/K+-ATPase","volume":"988","author":"Sweadner","year":"1989","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ceca.2019.102156_bib0135","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1074\/jbc.275.3.1976","article-title":"Transport and pharmacological properties of nine different human Na, K-ATPase isozymes","volume":"275","author":"Crambert","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ceca.2019.102156_bib0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000363301","article-title":"The role of cardiotonic steroids in the pathogenesis of cardiomyopathy in chronic kidney disease","volume":"128","author":"Pavlovic","year":"2014","journal-title":"Nephron Clin. Pract."},{"key":"10.1016\/j.ceca.2019.102156_bib0145","doi-asserted-by":"crossref","first-page":"C165","DOI":"10.1152\/ajpcell.1977.232.5.C165","article-title":"Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis","volume":"232","author":"Blaustein","year":"1977","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ceca.2019.102156_bib0150","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.RES.25.4.365","article-title":"Chronotropic effect of cardiac glycosides in cats, dogs, and rabbits","volume":"25","author":"Ten Eick","year":"1969","journal-title":"Circ. Res."},{"key":"10.1016\/j.ceca.2019.102156_bib0155","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/eurheartj\/ehs004","article-title":"Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failure","volume":"33","author":"Castagno","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ceca.2019.102156_bib0160","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1161\/01.HYP.17.6.936","article-title":"Development of an immunoassay for endogenous digitalislike factor","volume":"17","author":"Harris","year":"1991","journal-title":"Hypertension"},{"key":"10.1016\/j.ceca.2019.102156_bib0165","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/01.HYP.34.3.450","article-title":"Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension","volume":"34","author":"Manunta","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.ceca.2019.102156_bib0170","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0895-7061(00)01225-5","article-title":"Endogenous ouabain and hemodynamic and left ventricular geometric patterns in essential hypertension","volume":"14","author":"Pierdomenico","year":"2001","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ceca.2019.102156_bib0175","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1097\/HJH.0000000000001042","article-title":"Endogenous ouabain and aldosterone are coelevated in the circulation of patients with essential hypertension","volume":"34","author":"Tentori","year":"2016","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ceca.2019.102156_bib0180","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/01.CIR.86.2.420","article-title":"Elevated concentrations of endogenous ouabain in patients with congestive heart failure","volume":"86","author":"Gottlieb","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.ceca.2019.102156_bib0185","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/714793","article-title":"Endogenous Ouabain: An Old Cardiotonic Steroid as a New Biomarker of Heart Failure and a Predictor of Mortality after Cardiac Surgery","volume":"2015","author":"Simonini","year":"2015","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.ceca.2019.102156_bib0190","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1053\/j.ajkd.2018.10.012","article-title":"Lanosterol synthase genetic variants, endogenous ouabain, and both acute and chronic kidney injury","volume":"73","author":"Iatrino","year":"2019","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ceca.2019.102156_bib0195","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/ndt\/gfu200","article-title":"A new clinical multivariable model that predicts postoperative acute kidney injury: impact of endogenous ouabain","volume":"29","author":"Simonini","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ceca.2019.102156_bib0200","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/CCM.0b013e3182741599","article-title":"Preoperative endogenous ouabain predicts acute kidney injury in cardiac surgery patients","volume":"41","author":"Bignami","year":"2013","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ceca.2019.102156_bib0205","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2796.2007.01883.x","article-title":"Endogenous ouabain and cardiomyopathy in dialysis patients","volume":"263","author":"Stella","year":"2008","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ceca.2019.102156_bib0210","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0006-291X(05)80898-8","article-title":"Isolation of a urinary digitalis-like factor indistinguishable from digoxin","volume":"173","author":"Goto","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ceca.2019.102156_bib0215","doi-asserted-by":"crossref","first-page":"8731","DOI":"10.1074\/jbc.271.15.8731","article-title":"Deglycosylated products of endogenous digoxin-like immunoreactive factor in mammalian tissue","volume":"271","author":"Qazzaz","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ceca.2019.102156_bib0220","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/abbi.1996.0160","article-title":"Simultaneous isolation of endogenous digoxin-like immunoreactive factor, ouabain-like factor, and deglycosylated congeners from mammalian tissues","volume":"328","author":"Qazzaz","year":"1996","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ceca.2019.102156_bib0225","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/01.HYP.31.5.1097","article-title":"Characterization of a urinary bufodienolide Na+,K+-ATPase inhibitor in patients after acute myocardial infarction","volume":"31","author":"Bagrov","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.ceca.2019.102156_bib0230","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.clinbiochem.2004.08.005","article-title":"A novel endogenous digitalis, telocinobufagin, exhibits elevated plasma levels in patients with terminal renal failure","volume":"38","author":"Komiyama","year":"2005","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ceca.2019.102156_bib0235","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/01.HYP.27.5.1073","article-title":"Pulse pressure correlates in humans with a proscillaridin A immunoreactive compound","volume":"27","author":"Sich","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.ceca.2019.102156_bib0240","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0024-3205(00)01013-4","article-title":"Determination of bufalin-like immunoreactivity in serum of humans and rats by time-resolved fluoroimmunoassay for using a monoclonal antibody","volume":"68","author":"Oda","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.ceca.2019.102156_bib0245","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cca.2014.01.038","article-title":"No endogenous ouabain is detectable in human plasma by ultra-sensitive UPLC-MS\/MS","volume":"431","author":"Baecher","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ceca.2019.102156_bib0250","doi-asserted-by":"crossref","first-page":"C641","DOI":"10.1152\/ajpcell.00069.2018","article-title":"Reply to \u201cLetter to the editor: comments on Blaustein (2018):\u2019 the pump, the exchanger, and the holy spirit: origins and 40-year evolution of ideas about the ouabain-Na(+) pump endocrine system\u2019\u201d","volume":"314","author":"Blaustein","year":"2018","journal-title":"Am. J. Physiol., Cell Physiol."},{"key":"10.1016\/j.ceca.2019.102156_bib0255","doi-asserted-by":"crossref","first-page":"C3","DOI":"10.1152\/ajpcell.00196.2017","article-title":"The pump, the exchanger, and the holy spirit: origins and 40-year evolution of ideas about the ouabain-Na(+) pump endocrine system","volume":"314","author":"Blaustein","year":"2018","journal-title":"Am. J. Physiol., Cell Physiol."},{"key":"10.1016\/j.ceca.2019.102156_bib0260","doi-asserted-by":"crossref","first-page":"C640","DOI":"10.1152\/ajpcell.00034.2018","article-title":"Letter to the editor: Comments on Blaustein (2018): \u201cThe pump, the exchanger, and the holy spirit: origins and 40-year evolution of ideas about the ouabain-Na(+) pump endocrine system\u201d","volume":"314","author":"Vogeser","year":"2018","journal-title":"Am. J. Physiol., Cell Physiol."},{"key":"10.1016\/j.ceca.2019.102156_bib0265","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/HYPERTENSIONAHA.116.06599","article-title":"Endogenous ouabain: recent advances and controversies","volume":"68","author":"Hamlyn","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.ceca.2019.102156_bib0270","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1006\/bbrc.1995.1996","article-title":"Secretion of endogenous ouabain from bovine adrenocortical cells: role of the zona glomerulosa and zona fasciculata","volume":"212","author":"Laredo","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ceca.2019.102156_bib0275","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/01.HYP.36.3.442","article-title":"Mammalian bufadienolide is synthesized from cholesterol in the adrenal cortex by a pathway that is independent of cholesterol side-chain cleavage","volume":"36","author":"Dmitrieva","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.ceca.2019.102156_bib0280","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/CIRCULATIONAHA.105.554071","article-title":"Endogenous ouabain: upregulation of steroidogenic genes in hypertensive hypothalamus but not adrenal","volume":"112","author":"Murrell","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ceca.2019.102156_bib0285","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/HYPERTENSIONAHA.115.06415","article-title":"Lanosterol synthase gene polymorphisms and changes in endogenous ouabain in the response to low sodium intake","volume":"67","author":"Lanzani","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.ceca.2019.102156_bib0290","doi-asserted-by":"crossref","first-page":"R553","DOI":"10.1152\/ajpregu.00648.2005","article-title":"Salt intake and depletion increase circulating levels of endogenous ouabain in normal men, American journal of physiology","volume":"290","author":"Manunta","year":"2006","journal-title":"Regulatory, integrative and comparative physiology"},{"key":"10.1016\/j.ceca.2019.102156_bib0295","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/01.HYP.33.1.373","article-title":"Effects of angiotensin II on sodium potassium pumps, endogenous ouabain, and aldosterone in bovine zona glomerulosa cells","volume":"33","author":"Shah","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.ceca.2019.102156_bib0300","first-page":"845","article-title":"The inotropic effect of cardioactive glycosides in ventricular myocytes requires Na+-Ca2+ exchanger function","volume":"575","author":"Altamirano","year":"2006","journal-title":"J. Physiol. (Paris)"},{"key":"10.1016\/j.ceca.2019.102156_bib0305","doi-asserted-by":"crossref","first-page":"F922","DOI":"10.1152\/ajprenal.90605.2008","article-title":"The cardiotonic steroid hormone marinobufagenin induces renal fibrosis: implication of epithelial-to-mesenchymal transition","volume":"296","author":"Fedorova","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.ceca.2019.102156_bib0310","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3109\/10641969809053236","article-title":"Endogenous marinobufagenin-like factor in acute plasma volume expansion","volume":"20","author":"Fedorova","year":"1998","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.ceca.2019.102156_bib0315","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0009-8981(98)00032-1","article-title":"A non ouabain-like inhibitor of the sodium pump in uremic plasma ultrafiltrates and urine from healthy subjects","volume":"273","author":"Gallice","year":"1998","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ceca.2019.102156_bib0320","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/10641969809053240","article-title":"Simultaneous measurement of marinobufagenin, ouabain, and hypertension-associated protein in various disease states","volume":"20","author":"Gonick","year":"1998","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.ceca.2019.102156_bib0325","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0895-7061(01)02219-1","article-title":"Plasma OLC is elevated in mild experimental uremia but is not associated with hypertension","volume":"14","author":"Harwood","year":"2001","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ceca.2019.102156_bib0330","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/01.HYP.0000202594.82271.92","article-title":"Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy","volume":"47","author":"Kennedy","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ceca.2019.102156_bib0335","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.clinbiochem.2009.09.025","article-title":"Therapeutic monitoring of serum digoxin for patients with heart failure using a rapid LC-MS\/MS method","volume":"43","author":"Li","year":"2010","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ceca.2019.102156_bib0340","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1046\/j.1523-1755.2001.00053.x","article-title":"Effects of uremic serum on isolated cardiac myocyte calcium cycling and contractile function","volume":"60","author":"Periyasamy","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.ceca.2019.102156_bib0345","doi-asserted-by":"crossref","first-page":"27838","DOI":"10.1074\/jbc.M002950200","article-title":"Ouabain interaction with cardiac Na+\/K+-ATPase initiates signal cascades independent of changes in intracellular Na+ and Ca2+ concentrations","volume":"275","author":"Liu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ceca.2019.102156_bib0350","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1385\/CBB:46:3:303","article-title":"K-ATPase receptor complex: its organization and membership","volume":"46","author":"Pierre","year":"2006","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.ceca.2019.102156_bib0355","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00424-008-0470-0","article-title":"The Na\/K-ATPase\/Src complex and cardiotonic steroid-activated protein kinase cascades","volume":"457","author":"Li","year":"2009","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.ceca.2019.102156_bib0360","doi-asserted-by":"crossref","first-page":"10585","DOI":"10.1074\/jbc.M609181200","article-title":"Identification of a pool of non-pumping Na\/K-ATPase","volume":"282","author":"Liang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ceca.2019.102156_bib0365","doi-asserted-by":"crossref","first-page":"17250","DOI":"10.1074\/jbc.M313239200","article-title":"Ouabain assembles signaling cascades through the caveolar Na+\/K+-ATPase","volume":"279","author":"Wang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ceca.2019.102156_bib0370","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1111\/j.1523-1755.2005.00283.x","article-title":"Ouabain-induced endocytosis of the plasmalemmal Na\/K-ATPase in LLC-PK1 cells requires caveolin-1","volume":"67","author":"Liu","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.ceca.2019.102156_bib0375","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1523-1755.2004.00723.x","article-title":"Ouabain induces endocytosis of plasmalemmal Na\/K-ATPase in LLC-PK1 cells by a clathrin-dependent mechanism","volume":"66","author":"Liu","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.ceca.2019.102156_bib0380","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1046\/j.1523-1755.2002.00672.x","article-title":"Effects of cardiac glycosides on sodium pump expression and function in LLC-PK1 and MDCK cells","volume":"62","author":"Liu","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.ceca.2019.102156_bib0385","first-page":"181","article-title":"Involvement of mitogen-activated protein kinases and reactive oxygen species in the inotropic action of ouabain on cardiac myocytes","volume":"242","author":"Tian","year":"2003","journal-title":"A potential role for mitochondrial K(ATP) channels, Molecular and cellular biochemistry"},{"key":"10.1016\/j.ceca.2019.102156_bib0390","doi-asserted-by":"crossref","first-page":"10372","DOI":"10.1074\/jbc.271.17.10372","article-title":"Partial inhibition of Na+\/K+-ATPase by ouabain induces the Ca2+-dependent expressions of early-response genes in cardiac myocytes","volume":"271","author":"Peng","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ceca.2019.102156_bib0395","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1440-1681.2004.03995.x","article-title":"Nanomolar level of ouabain increases intracellular calcium to produce nitric oxide in rat aortic endothelial cells","volume":"31","author":"Dong","year":"2004","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ceca.2019.102156_bib0400","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1161\/hh0302.104562","article-title":"The Na+-Ca2+ exchanger is essential for the action of cardiac glycosides","volume":"90","author":"Reuter","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.ceca.2019.102156_bib0405","doi-asserted-by":"crossref","first-page":"37919","DOI":"10.1074\/jbc.M111.251777","article-title":"Ca2+ influx through reverse mode Na+\/Ca2+ exchange is critical for vascular endothelial growth factor-mediated extracellular signal-regulated kinase (ERK) 1\/2 activation and angiogenic functions of human endothelial cells","volume":"286","author":"Andrikopoulos","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ceca.2019.102156_bib0410","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jama.289.7.871","article-title":"Association of serum digoxin concentration and outcomes in patients with heart failure","volume":"289","author":"Rathore","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ceca.2019.102156_bib0415","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1113\/jphysiol.2013.266866","article-title":"Ouabain-digoxin antagonism in rat arteries and neurones","volume":"592","author":"Song","year":"2014","journal-title":"J. Physiol. (Lond.)"},{"key":"10.1016\/j.ceca.2019.102156_bib0420","article-title":"Ouabain-digoxin antagonism in rat arteries and neurones","author":"Song","year":"2013","journal-title":"J. Physiol. (Paris)"},{"key":"10.1016\/j.ceca.2019.102156_bib0425","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/eurheartj\/ehi687","article-title":"Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial","volume":"27","author":"Ahmed","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ceca.2019.102156_bib0430","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1161\/01.HYP.37.2.462","article-title":"Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats","volume":"37","author":"Fedorova","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.ceca.2019.102156_bib0435","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/j.1523-1755.2005.00285.x","article-title":"Salt loading induces redistribution of the plasmalemmal Na\/K-ATPase in proximal tubule cells","volume":"67","author":"Periyasamy","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.ceca.2019.102156_bib0440","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1124\/jpet.104.065250","article-title":"Characterization of the neutralizing activity of digoxin-specific Fab toward ouabain-like steroids","volume":"310","author":"Pullen","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ceca.2019.102156_bib0445","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/01.hjh.0000163153.27954.33","article-title":"Antibody to marinobufagenin lowers blood pressure in pregnant rats on a high NaCl intake","volume":"23","author":"Fedorova","year":"2005","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ceca.2019.102156_bib0450","doi-asserted-by":"crossref","first-page":"R1248","DOI":"10.1152\/ajpregu.00782.2007","article-title":"Endogenous sodium pump inhibitors and age-associated increases in salt sensitivity of blood pressure in normotensives","volume":"294","author":"Anderson","year":"2008","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ceca.2019.102156_bib0455","doi-asserted-by":"crossref","first-page":"15845","DOI":"10.1073\/pnas.0507358102","article-title":"The highly conserved cardiac glycoside binding site of Na,K-ATPase plays a role in blood pressure regulation","volume":"102","author":"Dostanic-Larson","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ceca.2019.102156_bib0460","doi-asserted-by":"crossref","first-page":"33306","DOI":"10.1074\/jbc.M402187200","article-title":"Organ hypertrophic signaling within caveolae membrane subdomains triggered by ouabain and antagonized by PST 2238","volume":"279","author":"Ferrandi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ceca.2019.102156_bib0465","doi-asserted-by":"crossref","first-page":"I106","DOI":"10.1161\/01.HYP.23.1_Suppl.I106","article-title":"Chronic blood pressure effects of bufalin, a sodium-potassium ATPase inhibitor, in rats","volume":"23","author":"Pamnani","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.ceca.2019.102156_bib0470","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00004872-199917080-00018","article-title":"Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia","volume":"17","author":"Lopatin","year":"1999","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ceca.2019.102156_bib0475","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1055\/s-0030-1249762","article-title":"Digoxin immune fab treatment for severe preeclampsia","volume":"27","author":"Adair","year":"2010","journal-title":"Am. J. Perinatol."},{"issue":"119","key":"10.1016\/j.ceca.2019.102156_bib0480","first-page":"e111","article-title":"Digoxin antibody fragment, antigen binding (Fab), treatment of preeclampsia in women with endogenous digitalis-like factor: a secondary analysis of the DEEP Trial","volume":"209","author":"Lam","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ceca.2019.102156_bib0485","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1097\/HJH.0b013e328200497a","article-title":"Intrahippocampal microinjection of an exquisitely low dose of ouabain mimics NaCl loading and stimulates a bufadienolide Na\/K-ATPase inhibitor","volume":"25","author":"Fedorova","year":"2007","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ceca.2019.102156_bib0490","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/hc0902.104710","article-title":"Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride--dependent hypertension","volume":"105","author":"Fedorova","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ceca.2019.102156_bib0495","doi-asserted-by":"crossref","first-page":"R529","DOI":"10.1152\/ajpregu.00518.2005","article-title":"Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adducin-dependent hypertension","volume":"290","author":"Ferrari","year":"2006","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ceca.2019.102156_bib0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10641950802629709","article-title":"Resibufogenin prevents the manifestations of preeclampsia in an animal model of the syndrome","volume":"29","author":"Horvat","year":"2010","journal-title":"Hypertension in pregnancy : official journal of the International Society for the Study of Hypertension in Pregnancy"},{"key":"10.1016\/j.ceca.2019.102156_bib0505","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1745-6215-12-13","article-title":"Main results of the ouabain and adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxin","volume":"12","author":"Staessen","year":"2011","journal-title":"Trials"},{"key":"10.1016\/j.ceca.2019.102156_bib0510","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/cvr\/25.5.371","article-title":"Endogenous plasma Na,K-ATPase inhibitory activity and digoxin like immunoreactivity after acute myocardial infarction","volume":"25","author":"Bagrov","year":"1991","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ceca.2019.102156_bib0515","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1161\/CIRCHEARTFAILURE.114.001976","article-title":"Elevated plasma marinobufagenin, an endogenous cardiotonic steroid, is associated with right ventricular dysfunction and nitrative stress in heart failure","volume":"8","author":"Kennedy","year":"2015","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ceca.2019.102156_bib0520","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejheart.2005.07.010","article-title":"Independent and incremental prognostic value of endogenous ouabain in idiopathic dilated cardiomyopathy","volume":"8","author":"Pitzalis","year":"2006","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ceca.2019.102156_bib0525","article-title":"Passive immunization against marinobufagenin attenuates renal fibrosis and improves renal function in experimental renal disease","author":"Haller","year":"2013","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ceca.2019.102156_bib0530","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-physiol-021909-135725","article-title":"The physiological significance of the cardiotonic steroid\/ouabain-binding site of the Na,K-ATPase","volume":"72","author":"Lingrel","year":"2010","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ceca.2019.102156_bib0535","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1093\/ndt\/gfn325","article-title":"Role of endogenous cardiotonic steroids in sodium homeostasis","volume":"23","author":"Schoner","year":"2008","journal-title":"Nephrol. Dial. Transplant."}],"container-title":["Cell Calcium"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143416019302258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143416019302258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T20:28:20Z","timestamp":1758918500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143416019302258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":107,"alternative-id":["S0143416019302258"],"URL":"https:\/\/doi.org\/10.1016\/j.ceca.2019.102156","relation":{},"ISSN":["0143-4160"],"issn-type":[{"value":"0143-4160","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endogenous cardiotonic steroids and cardiovascular disease, where to next?","name":"articletitle","label":"Article Title"},{"value":"Cell Calcium","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ceca.2019.102156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102156"}}